ArticlesFull Access
Published Online:21 Mar 2017https://doi.org/10.1176/appi.ajp.2017.16091037
- Cited by
- 4 January 2024 | Journal of Patient-Reported Outcomes, Vol. 8, No. 1
- 20 May 2024 | Journal of Clinical Psychopharmacology, Vol. 3
- 18 April 2024 | Journal of Clinical Psychopharmacology, Vol. 44, No. 3
- 19 March 2024 | CNS Drugs, Vol. 38, No. 4
- Tremor and Other Hyperkinetic Movements, Vol. 14, No. 1
- Journal of Clinical Psychopharmacology, Vol. 44, No. 2
- 19 January 2024 | Psychopharmacology, Vol. 241, No. 2
- Clinical Therapeutics, Vol. 45, No. 12
- Impact of tardive dyskinesia on patients and caregivers: a survey of caregivers in the United States28 November 2023 | Journal of Patient-Reported Outcomes, Vol. 7, No. 1
- Valbenazine promotes body growth via growth hormone signaling during zebrafish embryonic developmentToxicology and Applied Pharmacology, Vol. 477
- Cell Reports Medicine, Vol. 4, No. 10
- 12 September 2023 | International Clinical Psychopharmacology, Vol. 4
- 19 June 2023 | Journal of Clinical Psychopharmacology, Vol. 43, No. 4
- 20 April 2023 | Movement Disorders, Vol. 38, No. 6
- 18 December 2022 | Clinical Pharmacology in Drug Development, Vol. 12, No. 4
- 14 December 2022 | Telemedicine and e-Health, Vol. 13
- 29 July 2022 | Journal of Neurology, Vol. 269, No. 11
- 17 September 2022 | Psychiatry and Clinical Neurosciences, Vol. 76, No. 11
- 24 October 2022 | CNS Spectrums, Vol. 39
- 22 August 2022 | InFo Neurologie + Psychiatrie, Vol. 24, No. 7-8
- Journal of Psychiatric Research, Vol. 151
- 20 November 2020 | CNS Spectrums, Vol. 27, No. 2
- Wireless Communications and Mobile Computing, Vol. 2022
- Disease Markers, Vol. 2022
- 21 October 2022 | Therapeutic Advances in Psychopharmacology, Vol. 12
- 2 December 2021
- 15 February 2021 | BMC Psychiatry, Vol. 21, No. 1
- 9 August 2021 | Issues in Mental Health Nursing, Vol. 81
- 18 May 2020 | CNS Spectrums, Vol. 26, No. 4
- 1 April 2021 | Expert Review of Neurotherapeutics, Vol. 21, No. 4
- 13 July 2020 | The International Journal of Psychiatry in Medicine, Vol. 56, No. 2
- 25 June 2020 | Nordic Journal of Psychiatry, Vol. 75, No. 1
- 20 January 2021 | Journal of Medical Economics, Vol. 24, No. 1
- 19 July 2021 | Journal of Medical Economics, Vol. 24, No. 1
- 19 July 2021 | Journal of Medical Economics, Vol. 24, No. 1
- 18 June 2021 | Health Psychology Research, Vol. 9, No. 1
- Case Reports in Psychiatry, Vol. 2020
- 1 September 2020 | American Journal of Health-System Pharmacy, Vol. 77, No. 24
- Clinical Psychopharmacology and Neuroscience, Vol. 18, No. 4
- Schizophrenia Research, Vol. 225
- 6 July 2020 | Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, Vol. 47, No. 6
- 29 October 2020 | Pharmaceutics, Vol. 12, No. 11
- Neurotherapeutics, Vol. 17, No. 4
- Neurotherapeutics, Vol. 17, No. 4
- 25 May 2020 | Behavioural Pharmacology, Vol. 31, No. 6
- Parkinsonism & Related Disorders, Vol. 77
- Pharmacology & Therapeutics, Vol. 212
- Tremor and Other Hyperkinetic Movements, Vol. 10, No. 1
- 14 April 2020 | Expert Opinion on Pharmacotherapy, Vol. 21, No. 5
- 21 February 2020 | Neurology, Neuropsychiatry, Psychosomatics, Vol. 12, No. 1
- 24 January 2020 | American Journal of Health-System Pharmacy, Vol. 77, No. 3
- 30 October 2019 | Expert Opinion on Pharmacotherapy, Vol. 21, No. 1
- Clinical Parkinsonism & Related Disorders, Vol. 3
- 12 December 2019 | Journal of Psychopharmacology, Vol. 34, No. 1
- 22 April 2020 | Clinical Research In Practice: The Journal of Team Hippocrates, Vol. 6, No. 1
- 31 October 2019 | International Journal of Geriatric Psychiatry, Vol. 35, No. 1
- 30 October 2019 | Journal of Clinical Psychopharmacology, Vol. 39, No. 6
- 4 November 2019 | Journal of Clinical Psychopharmacology, Vol. 39, No. 6
- Journal of Comparative Effectiveness Research, Vol. 8, No. 13
- 16 August 2019 | Current Neurology and Neuroscience Reports, Vol. 19, No. 9
- The Lancet Neurology, Vol. 18, No. 9
- 4 September 2019 | CNS Spectrums, Vol. 24, No. S1
- 18 February 2018 | Journal of Pharmacy Practice, Vol. 32, No. 4
- 24 June 2019 | Movement Disorders, Vol. 34, No. 8
- 28 May 2019 | Drugs & Therapy Perspectives, Vol. 35, No. 7
- 21 February 2019 | The Canadian Journal of Psychiatry, Vol. 64, No. 6
- Journal of Psychosocial Nursing and Mental Health Services, Vol. 57, No. 5
- 6 February 2019 | Neurodegenerative Disease Management, Vol. 9, No. 2
- Journal of Affective Disorders, Vol. 246
- 20 May 2019 | Therapeutic Advances in Psychopharmacology, Vol. 9
- 7 September 2018 | World Psychiatry, Vol. 17, No. 3
- 8 May 2018 | Movement Disorders, Vol. 33, No. 7
- 2 April 2018 | Expert Review of Neurotherapeutics, Vol. 18, No. 4
- 23 January 2018 | Expert Review of Clinical Pharmacology, Vol. 11, No. 3
- 19 March 2018 | Cochrane Database of Systematic Reviews, Vol. 2018, No. 3
- Journal of Comparative Effectiveness Research, Vol. 7, No. 2
- 25 October 2017 | The Brown University Psychopharmacology Update, Vol. 28, No. 11
- 31 July 2017 | Expert Review of Neurotherapeutics, Vol. 17, No. 9
- 3 August 2017 | Expert Review of Neurotherapeutics, Vol. 17, No. 9
- 2 August 2017 | Expert Opinion on Pharmacotherapy, Vol. 18, No. 12
Metrics
Critical review of manuscript drafts was provided by Dr. Scott Siegert, a full-time employee of Neurocrine Biosciences. Writing and editorial assistance were provided by Mildred Bahn, of Prescott Medical Communications Group (Chicago), with support from Neurocrine Biosciences.
History
Received 15 September 2016
Revised 17 January 2017
Accepted 9 February 2017
Published online 21 March 2017
Published in print 1 May 2017